| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2022 | Dec 30, 2022 | Athira Pharma, Inc. | CFO | Buy | 95.0 | +50,763 | 46.50% | ✗ | $142.3K |
| May 18, 2022 | Jun 24, 2022 | Athira Pharma, Inc. | CFO | Sell | 85.0 | +9,107 | 9.10% | ✗ | $7K |